XML 39 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Share-based Payment Arrangements (Tables)
6 Months Ended
Jun. 26, 2021
Amounts Recognized in Financial Statements with Respect to Plans Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands):
                                                                                                                 
   
Twenty Six Weeks Ended
   
Thirteen Weeks Ended
 
 
 
June 26,

2021
   
June 27,

2020
   
June 26,

2021
   
June 27,

2020
 
Total cost of the Plans during the period
 
$
10,893
 
 
$
1,201
 
 
$
6,864
 
 
$
570
 
Amount of related income tax benefit recognized during the period
 
 
(3,717
 
 
(1,135
 
 
(2,376
 
 
(262
)
   
 
 
   
 
 
   
 
 
   
 
 
 
Net cost of the Plans during the period
 
$
7,176
 
 
$
66
 
 
$
4,488
 
 
$
308
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Schedule of Information on Restricted Stock Units
The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans:
 
    
Number of
    
Weighted Average
Grant Date
 
    
RSUs
    
Fair Value
 
Outstanding at December 26, 2020
     183,213      $ 93.44  
Granted
     45,864      $ 128.93  
Shares earned in excess of target
(1)
     7,132      $ 31.97  
Vested shares
     (24,600    $ 59.85  
    
 
 
          
Outstanding at June 26, 2021
     211,609      $ 102.97  
    
 
 
          
 
(1)
Represents shares earned in excess of target under the May 1, 2015 RSU award as total shareholder return exceeded the target under the award.
Summary of Information Regarding Stock Options
The following table summarizes information regarding the Company’s outstanding stock options under the Plans:
 
    
Number of
Options
   
Weighted
Average Exercise
Price per Share
    
Weighted Average
Remaining
Contractual
Term (years)
    
Aggregate Intrinsic
Value (000s)
 
Options outstanding at December 26, 2020
     17,650      $ 54.16                    
Exercised
     (5,280    $ 51.83                    
    
 
 
                            
Options outstanding at June 26, 2021
     12,370      $ 55.15        1.3      $ 1,304  
    
 
 
                            
Options exercisable at June 26, 2021
     12,370      $ 55.15        1.3      $ 1,304  
    
 
 
                            
The total intrinsic value of stock options exercised during the
twenty-six-week
 
periods ended June 26, 2021 and June 27, 2020 was $
521,000
and $
1,071,000
, respectively.
Schedule of Information on Non-Vested Restricted Stock and Deferred Stock Units
The following table summarizes information regarding the Company’s outstanding shares of
non-vested
restricted stock and Deferred Stock
Units
(defined below) under the Plans:
    
Number of Shares

and Deferred Stock
Units
    
Weighted Average

Grant Date

Fair Value
 
Non-vested
at December 26, 2020
     60,440      $ 103.65  
Granted
     26,351      $ 150.20  
Vested
     (29,055    $ 104.35  
    
 
 
          
Non-vested
at June 26, 2021
     57,736      $ 124.55